NATURES SUNSHINE PRODS INC (NATR)

US6390271012 - Common Stock

14.65  +0.09 (+0.62%)

After market: 14.65 0 (0%)

Fundamental Rating

6

Overall NATR gets a fundamental rating of 6 out of 10. We evaluated NATR against 36 industry peers in the Personal Care Products industry. While NATR has a great health rating, its profitability is only average at the moment. NATR has a decent growth rate and is not valued too expensively.



6

1. Profitability

1.1 Basic Checks

In the past year NATR was profitable.
NATR had a positive operating cash flow in the past year.
Of the past 5 years NATR 4 years were profitable.
NATR had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of 6.92%, NATR is doing good in the industry, outperforming 74.29% of the companies in the same industry.
With a decent Return On Equity value of 10.85%, NATR is doing good in the industry, outperforming 77.14% of the companies in the same industry.
The Return On Invested Capital of NATR (9.38%) is better than 68.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NATR is below the industry average of 13.52%.
Industry RankSector Rank
ROA 6.92%
ROE 10.85%
ROIC 9.38%
ROA(3y)5.67%
ROA(5y)5.75%
ROE(3y)9.25%
ROE(5y)9.34%
ROIC(3y)10.54%
ROIC(5y)10.14%

1.3 Margins

With a decent Profit Margin value of 3.81%, NATR is doing good in the industry, outperforming 62.86% of the companies in the same industry.
In the last couple of years the Profit Margin of NATR has declined.
NATR has a Operating Margin of 4.75%. This is comparable to the rest of the industry: NATR outperforms 57.14% of its industry peers.
In the last couple of years the Operating Margin of NATR has grown nicely.
With a decent Gross Margin value of 71.43%, NATR is doing good in the industry, outperforming 71.43% of the companies in the same industry.
NATR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.75%
PM (TTM) 3.81%
GM 71.43%
OM growth 3Y-1.75%
OM growth 5Y29.97%
PM growth 3Y-15.09%
PM growth 5YN/A
GM growth 3Y-0.72%
GM growth 5Y-0.45%

8

2. Health

2.1 Basic Checks

NATR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, NATR has less shares outstanding
NATR has less shares outstanding than it did 5 years ago.
NATR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

NATR has an Altman-Z score of 4.73. This indicates that NATR is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.73, NATR is doing good in the industry, outperforming 65.71% of the companies in the same industry.
There is no outstanding debt for NATR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.73
ROIC/WACC1
WACC9.35%

2.3 Liquidity

A Current Ratio of 2.44 indicates that NATR has no problem at all paying its short term obligations.
With a Current ratio value of 2.44, NATR perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
A Quick Ratio of 1.51 indicates that NATR should not have too much problems paying its short term obligations.
NATR has a better Quick ratio (1.51) than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.51

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.00% over the past year.
Measured over the past years, NATR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.21% on average per year.
NATR shows a small growth in Revenue. In the last year, the Revenue has grown by 1.36%.
The Revenue has been growing slightly by 4.07% on average over the past years.
EPS 1Y (TTM)45%
EPS 3Y-10.21%
EPS 5YN/A
EPS Q2Q%53.33%
Revenue 1Y (TTM)1.36%
Revenue growth 3Y4.95%
Revenue growth 5Y4.07%
Sales Q2Q%3.07%

3.2 Future

The Earnings Per Share is expected to decrease by -0.77% on average over the next years.
Based on estimates for the next years, NATR will show a small growth in Revenue. The Revenue will grow by 1.85% on average per year.
EPS Next Y-31.28%
EPS Next 2Y-6.66%
EPS Next 3Y-0.77%
EPS Next 5YN/A
Revenue Next Year-0.53%
Revenue Next 2Y1.04%
Revenue Next 3Y1.85%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.84, which indicates a correct valuation of NATR.
Compared to the rest of the industry, the Price/Earnings ratio of NATR indicates a somewhat cheap valuation: NATR is cheaper than 77.14% of the companies listed in the same industry.
NATR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
With a Price/Forward Earnings ratio of 17.70, NATR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, NATR is valued a bit cheaper than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, NATR is valued a bit cheaper.
Industry RankSector Rank
PE 16.84
Fwd PE 17.7

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NATR indicates a rather cheap valuation: NATR is cheaper than 88.57% of the companies listed in the same industry.
NATR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NATR is cheaper than 65.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.34
EV/EBITDA 5.58

4.3 Compensation for Growth

NATR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.66%
EPS Next 3Y-0.77%

0

5. Dividend

5.1 Amount

No dividends for NATR!.
Industry RankSector Rank
Dividend Yield N/A

NATURES SUNSHINE PRODS INC

NASDAQ:NATR (1/3/2025, 8:00:01 PM)

After market: 14.65 0 (0%)

14.65

+0.09 (+0.62%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners65.91%
Inst Owner Change-0.09%
Ins Owners5.35%
Ins Owner Change-0.14%
Market Cap270.73M
Analysts82.5
Price Target22.44 (53.17%)
Short Float %0.64%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.74%
Min EPS beat(2)-72.55%
Max EPS beat(2)61.06%
EPS beat(4)2
Avg EPS beat(4)37.96%
Min EPS beat(4)-72.55%
Max EPS beat(4)194.12%
EPS beat(8)6
Avg EPS beat(8)393.63%
EPS beat(12)8
Avg EPS beat(12)305.9%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.16%
Min Revenue beat(2)-3.47%
Max Revenue beat(2)3.15%
Revenue beat(4)1
Avg Revenue beat(4)-1.59%
Min Revenue beat(4)-3.9%
Max Revenue beat(4)3.15%
Revenue beat(8)4
Avg Revenue beat(8)1.04%
Revenue beat(12)6
Avg Revenue beat(12)1.91%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.76%
PT rev (3m)12.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.76%
EPS NY rev (1m)0%
EPS NY rev (3m)25.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.47%
Valuation
Industry RankSector Rank
PE 16.84
Fwd PE 17.7
P/S 0.61
P/FCF 21.34
P/OCF 11.92
P/B 1.73
P/tB 1.73
EV/EBITDA 5.58
EPS(TTM)0.87
EY5.94%
EPS(NY)0.83
Fwd EY5.65%
FCF(TTM)0.69
FCFY4.69%
OCF(TTM)1.23
OCFY8.39%
SpS24.09
BVpS8.47
TBVpS8.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.92%
ROE 10.85%
ROCE 11.87%
ROIC 9.38%
ROICexc 16.8%
ROICexgc 16.8%
OM 4.75%
PM (TTM) 3.81%
GM 71.43%
FCFM 2.85%
ROA(3y)5.67%
ROA(5y)5.75%
ROE(3y)9.25%
ROE(5y)9.34%
ROIC(3y)10.54%
ROIC(5y)10.14%
ROICexc(3y)19.46%
ROICexc(5y)18.47%
ROICexgc(3y)19.46%
ROICexgc(5y)18.49%
ROCE(3y)13.35%
ROCE(5y)12.88%
ROICexcg growth 3Y2.45%
ROICexcg growth 5Y30.78%
ROICexc growth 3Y2.45%
ROICexc growth 5Y30.99%
OM growth 3Y-1.75%
OM growth 5Y29.97%
PM growth 3Y-15.09%
PM growth 5YN/A
GM growth 3Y-0.72%
GM growth 5Y-0.45%
F-Score8
Asset Turnover1.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 75.66%
Cap/Sales 2.25%
Interest Coverage 38.05
Cash Conversion 66.02%
Profit Quality 74.73%
Current Ratio 2.44
Quick Ratio 1.51
Altman-Z 4.73
F-Score8
WACC9.35%
ROIC/WACC1
Cap/Depr(3y)72.53%
Cap/Depr(5y)62.28%
Cap/Sales(3y)1.89%
Cap/Sales(5y)1.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45%
EPS 3Y-10.21%
EPS 5YN/A
EPS Q2Q%53.33%
EPS Next Y-31.28%
EPS Next 2Y-6.66%
EPS Next 3Y-0.77%
EPS Next 5YN/A
Revenue 1Y (TTM)1.36%
Revenue growth 3Y4.95%
Revenue growth 5Y4.07%
Sales Q2Q%3.07%
Revenue Next Year-0.53%
Revenue Next 2Y1.04%
Revenue Next 3Y1.85%
Revenue Next 5YN/A
EBIT growth 1Y61.19%
EBIT growth 3Y3.11%
EBIT growth 5Y35.26%
EBIT Next Year83.68%
EBIT Next 3Y29.26%
EBIT Next 5YN/A
FCF growth 1Y170.48%
FCF growth 3Y-2.08%
FCF growth 5Y12.58%
OCF growth 1Y98.17%
OCF growth 3Y3.06%
OCF growth 5Y13.56%